Spots Global Cancer Trial Database for interferon
Every month we try and update this database with for interferon cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| TKI and Interferon Alpha Evaluation Initiated by the German Chronic Myeloid Leukemia Study Group - the TIGER Study | NCT01657604 | Chronic Myeloid... | Peginterferon α... Nilotinib | 18 Years - | University of Jena | |
| Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer | NCT00001228 | Islet Cell Aden... Zollinger Ellis... | Interferon | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas | NCT02323659 | Lymphoma, T-Cel... Mycosis Fungoid... | Methotrexate Interferon Alfa... | 18 Years - | Polish Lymphoma Research Group | |
| Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia | NCT00333840 | Chronic Myeloge... | imatinib mesila... interferon-alph... cytarabine (ARA... | 18 Years - 70 Years | Novartis | |
| TKI and Interferon Alpha Evaluation Initiated by the German Chronic Myeloid Leukemia Study Group - the TIGER Study | NCT01657604 | Chronic Myeloid... | Peginterferon α... Nilotinib | 18 Years - | University of Jena | |
| Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma | NCT00963664 | Melanoma Malignant Melan... | lovastatin interferon alfa... | 18 Years - | NeoPlas Innovation | |
| Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer | NCT00001228 | Islet Cell Aden... Zollinger Ellis... | Interferon | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Cognitive Effects of Interferon in Patients With Melanoma | NCT02074605 | Melanoma | Interferon alph... | 18 Years - | University of Arizona | |
| Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors | NCT04053673 | Solid Tumor, Ad... | RBN-2397 | 18 Years - | Ribon Therapeutics, Inc. | |
| The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PV | NCT03003325 | Polycythemia Ve... | AOP2014 Phlebotomies ASA | 18 Years - 60 Years | FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS | |
| Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C | NCT00309530 | Colon Cancer St... | 5-fluorouracil,... | 18 Years - 80 Years | Austrian Breast & Colorectal Cancer Study Group | |
| The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PV | NCT03003325 | Polycythemia Ve... | AOP2014 Phlebotomies ASA | 18 Years - 60 Years | FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS | |
| Safety and Efficacy of Immune Therapy for Condyloma | NCT03158480 | Condylomata Acu... | DC-CIK immunoth... | 20 Years - 50 Years | Shenzhen Second People's Hospital | |
| Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic Leukemia | NCT00962715 | Chronic Lymphoc... | Influenza Vacci... Pegylated inter... Interferon (IFN... | 18 Years - | M.D. Anderson Cancer Center | |
| STI571 ProspectIve RandomIzed Trial: SPIRIT | NCT00219739 | Chronic Myeloid... | Imatinib mesyla... Imatinib mesyla... Imatinib 400 mg... Imatinib mesyla... | 18 Years - | Poitiers University Hospital | |
| Tumor Registry of Advanced Renal Cell Carcinoma | NCT00610012 | Renal Cell Carc... | 18 Years - | iOMEDICO AG | ||
| IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic Melanoma | NCT01409187 | Melanoma | Ipilimumab Interferon Interleukin-2 (... | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors | NCT04053673 | Solid Tumor, Ad... | RBN-2397 | 18 Years - | Ribon Therapeutics, Inc. | |
| SYTHROM Cohort, Myeloproliferative Neoplasia With Normal CBC and Thrombotic Complications | NCT04539678 | Thrombotic Pati... Diagnosis of My... Impact of Treat... | 18 Years - | Nantes University Hospital | ||
| A Study to Assess Sorafenib Alone and in Combination With Low-Dose Interferon Following Unsuccessful Treatment With Sunitinib in Patients With Advanced Renal Cell Cancer. | NCT00678288 | Carcinoma, Rena... | Sorafenib (Nexa... Sorafenib (Nexa... | 18 Years - | Bayer | |
| Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients | NCT00577993 | Lymphoma | Fludarabine Novantrone Decadron Rituximab Interferon Doxorubicin Vincristine Bleomycin Cyclophosphamid... Etoposide Cisplatin Ara-C Methyl-Predniso... Procarbazine Prednisone | - 76 Years | M.D. Anderson Cancer Center | |
| IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic Melanoma | NCT01409187 | Melanoma | Ipilimumab Interferon Interleukin-2 (... | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia | NCT00390897 | Chronic Myeloid... | Glivec Interferon | 18 Years - 72 Years | PETHEMA Foundation | |
| Addition of P1101 to Imatinib Treatment in Patients With Chronic Phase Chronic Myeloid Leukaemia Not Achieving a Complete Molecular Response | NCT01933906 | Chronic Phase C... | P1101 | 18 Years - | Arbeitsgemeinschaft medikamentoese Tumortherapie | |
| Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia | NCT00333840 | Chronic Myeloge... | imatinib mesila... interferon-alph... cytarabine (ARA... | 18 Years - 70 Years | Novartis | |
| Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C | NCT00309530 | Colon Cancer St... | 5-fluorouracil,... | 18 Years - 80 Years | Austrian Breast & Colorectal Cancer Study Group | |
| BAY43-9006 (Sorafenib) Versus Interferon Alpha-2a in Patients With Unresectable and/or Metastatic Renal Cell Carcinoma | NCT00117637 | Carcinoma, Rena... | Sorafenib (Nexa... Interferon | 18 Years - | Bayer | |
| Study on Screening, Verification and Intervention of High-risk Patients With Liver Cancer | NCT05721300 | Hepatocellular ... Chronic Hepatit... | NAs（"Entecavir"... NAs （"Entecavir... | 35 Years - 75 Years | Zhongshan Hospital (Xiamen), Fudan University | |
| Markers of Response to Intravesical Bladder Cancer Therapy | NCT01007058 | Bladder Cancer | 18 Years - | M.D. Anderson Cancer Center | ||
| A Phase II Study of Imatinib Versus Interferon as Adjuvant Therapy in KIT-mutated Melanoma | NCT01782508 | Melanoma | imatinib Interferon | 18 Years - | Peking University Cancer Hospital & Institute | |
| STI571 ProspectIve RandomIzed Trial: SPIRIT | NCT00219739 | Chronic Myeloid... | Imatinib mesyla... Imatinib mesyla... Imatinib 400 mg... Imatinib mesyla... | 18 Years - | Poitiers University Hospital | |
| Maintenance Therapy After Thalidomide-Dexamethasone(ThaDD) for Multiple Myeloma(MM) | NCT00633542 | Multiple Myelom... | thalidomide interferon alph... | 18 Years - | Università Politecnica delle Marche | |
| Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C | NCT00309530 | Colon Cancer St... | 5-fluorouracil,... | 18 Years - 80 Years | Austrian Breast & Colorectal Cancer Study Group | |
| Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia | NCT00390897 | Chronic Myeloid... | Glivec Interferon | 18 Years - 72 Years | PETHEMA Foundation | |
| Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma | NCT00963664 | Melanoma Malignant Melan... | lovastatin interferon alfa... | 18 Years - | NeoPlas Innovation | |
| Efficacy and Safety of Azacitidine Combined With Interferon in the Treatment of Post-transplant Recurrence | NCT04078399 | HSCT Efficacy and Sa... | Azacitidine com... | 14 Years - | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
